Turning to medications to help you reach your weight loss goals was once taboo, but with new advancements and telehealth ...

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...

FDA's April 1, 2026, update to its compounding policy page follows more than 18 months of regulatory activity surrounding the compounding of GLP-1 medications ...

GLP-1 medications like Ozempic and Wegovy are used for weight loss and diabetes. Learn how they work, their costs, and potential side effects.

Hims & Hers reversed course on its launch of a cheaper, copycat version of Novo Nordisk’s GLP-1 weight loss pill amid legal action. In a Feb. 7 social media post, the San Francisco-based telehealth ...

Hims & Hers Health is partnering with Novo Nordisk to expand access to FDA-approved GLP-1 weight loss medications through its U.S. platform. The agreement includes Ozempic injections in 0.5-, 1- and 2 ...

As more Americans turn to GLP-1s for weight loss, more overdoses from these drugs are being reported. Here's what to look out ...

FDA enforcement will focus on restricting GLP-1 APIs in mass-marketed, nonapproved compounded products to address unverifiable quality, safety, and efficacy under the FD&C Act. Appropriate compounding ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A GLP-1 injection pen, now just a few clicks away, raising questions about convenience, ...

While GLP-1 weight loss meds have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, Wegovy recently ...

For millions of people taking weight loss drugs, the next breakthrough may not be more weight loss.

OpenLoop, a company providing operational and tech services to telehealth companies, and compounding pharmacy Triad Rx are being sued in a class action for selling oral tirzepatide. The complaint (PDF ...